ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend

Bulletin Express

Aug 14

Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:

• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026. • Considering the declaration of an interim dividend, if any.

The notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1157826009"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1157826009\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1157826009?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 17:27","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1157826009","market":"hk","top_or_hot":-1,"title":"ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend","media":"Bulletin Express","content":"<p>Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:</p>\n<p>• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026.  \n• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZHONGZHIPHARM Sets 26 Aug 2026 Board Meeting to Review H1 2026 Results and Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 17:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:</p>\n<p>• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026.  \n• Considering the declaration of an interim dividend, if any.</p>\n<p>The notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03737","symbol_name":"中智药业","start_time":0,"source_url":"","article_id":"1157826009","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1157826009","pubTimestamp":1786699669,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes: • Reviewing and approving the unaudited...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03737":"中智药业"},"translate_title":"中植医药定于 2026 年 8 月 26 日召开董事会会议，审查 2026 年上半年业绩和中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03737":1},"content_text":"Zhongzhi Pharmaceutical Holdings Limited (ZHONGZHIPHARM) has scheduled a board meeting for 26 August 2026 at its Hong Kong headquarters. The agenda includes:\n• Reviewing and approving the unaudited consolidated results for the six months ended 30 June 2026.  \n• Considering the declaration of an interim dividend, if any.\nThe notice was released on 14 August 2026 and signed by Chairman and Executive Director Mr. Lai Zhi Tian. The Board currently comprises eight members: four executive directors (Mr. Lai Zhi Tian, Mr. Lai Ying Feng, Mr. Lai Ying Sheng, Mr. Cao Xiao Jun), one non-executive director (Ms. Jiang Li Xia) and three independent non-executive directors (Mr. Ng Kwun Wan, Mr. Zhu Shang Heng, Mr. Zhou Dai Han).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}